OCT West Coast: how can decentralisation help optimise rare disease trials?
Throughout the Covid-19 pandemic, decentralised clinical trials (DCTs) have been imperative for the continuation of...
Real-world setting study shows Velphoro effective in CKD-HP management
On 1 February, the Clinical Kidney Journal published results from a real-world setting study, the...
Spotlight on mRNA vaccines: Covid-19 approvals highlight a novel competitive landscape in oncology
The ongoing Covid-19 pandemic has yielded an unexpected advancement in the pharmaceutical industry with the...
How Covid-19 has accelerated ‘digital health’ and the evolution of clinical trials
The monumental challenges brought about by the Covid-19 pandemic have forced the healthcare and life...
Roche’s Ocrevus set to top $7.6bn in sales by 2028 backed by new dosing approval
On 14 December, the US Food and Drug Administration (FDA) approved a shorter two-hour infusion...
Hope for chronic kidney disease as KBP Biosciences’ KBP-5074 shows promise
In early December, KBP Biosciences shared results for their BLOCK-CKD Phase IIb study, which has...
